Pharmaceutical Outcomes and Policy
Identifying and improving the economic and health outcomes of therapies, policies and practices
The Division of Pharmaceutical Outcomes and Policy (DPOP) prepares graduates for leadership positions in academia, industry, and government sectors. Students develop solid research skills, enabling them to conduct high quality research directed at improving the use and cost-effectiveness of pharmaceutical products, technology, and services in society.
You can learn more about the division’s 5-year strategic plan here.
Our faculty are trained in public health and have expertise in: pharmacoepidemiology, genomic epidemiology, health behavior and behavior change (including the effects of patient-provider communication, risk communication, and health literacy on health behavior), comparative effectiveness research, pharmaceutical policy, and pharmacoeconomics.
We are training our students in the effectiveness and costs of medications, how patients take their medications, and the impact of drug policies on health outcomes of vulnerable people. Our PhD program offers three different concentrations: Pharmaceutical Policy and Economics, Pharmaco-Epidemiology and Social and Behavioral Health.
You can learn more about our PhD program here.
DPOP is committed to excellence in research, education, and service that advances the optimal use of medications with the goal of improving human health. Our research focuses on health outcomes and how to support medication taking at the individual, practice, and system level.
You can learn more about our current research here.
You can learn more about our Postdoctoral Fellowship programs here.
You can learn more about our faculty labs here.